Our goal is to ease and facilitate the entry of new pharma companies into India while helping existing companies attain a competitive edge.
By leveraging IMS’ new technology-enabled information assets and consulting services, pharma companies across India and across the globe can create and validate strategies that ultimately drive not only success, but also sustainability in this highly competitive market.
IMS Health's offerings enable us to support better decision-making regarding a wide range of business-critical issues including: growth planning, marketing and brand strategy, commercial effectiveness, product launch, sales force strategy, pricing, market access, reimbursement and field force deployment.
Local Information and Analytics
IMS Local Information & Analytics offerings leverage our unparalleled access to data and market intelligence in India. Using technology platforms to enable optimal data extraction, we are able to provide the critical visibility and the insights necessary to developing and validating business strategies.
IMS Total Sales Audit (TSA): A total view of secondary sales of pharma products in both units and dollars, allowing estimates of market size, sales performance and competitive analysis across retail, hospital and clinic channels.
IMS Stockist Secondary Audit (SSA): Secondary sales of pharma products in units and dollars to pharmacies and sub-stockists.
IMS Indian Pharmaceutical Audit (IIPA): Primary sales from pharma companies to stockists across multiple therapy areas and geographies.
IMS Medical Audit (Rx Data): Tracks prescriptions of doctors across 19 specialties on a monthly basis, at a national and sub-national level.
IMS Hospital Navigator (IHN): A comprehensive overview of India’s hospital network, including details on facilities, capacities, capabilities, patient traffic and other key data points.
Global Market Measurement
IMS Global Market Measurement (GMM) offerings provide pharma companies with unparalleled access to customized and/or strategically categorized data and analytics, as well as critical forecasting models. From understanding the rise of generics and branded biosimilars, to emerging trends in the consumer health/OTC market, GMM enables cross-country comparisons, across the product life cycle so companies gain a truly global, timely and cost-effective view of estimated product volumes, trends and market share through retail and non-retail channels.
| PHARMA SUPPLY CHAIN | FORECASTING | |
| IMS World Review Molecule IMS World Review Pack IMS World Review trader IMS Generic Market Development IMS World Review Series | IMS Market Prognosis IMS Therapy Forecaster IMS Analogue Planner IMS New Product Spectra | |
| IMS MIDAS | MARKET MEASUREMENT | |
| IMS MIDAS Customized Insights IMS MIDAS Quantum | IMS World Review Suite IMS KiloChem IMS ChemIndex | |
| LIFECYCLE & PORTFOLIO MGMT IMS Knowledge Link IMS Life Cycle | COMPETITIVE INTELLIGENCE IMS Company Profiles IMS PharmaDeals | |
Consulting Services
IMS India Consulting Group partners with stakeholders across pharmaceuticals, devices and diagnostics, and allied life-sciences to drive informed, strategic decisions. From competitive benchmarking and marketing strategies, to product and portfolio investment decisions, our team delivers the insights that drive results. The Consulting Group also delivers cutting-edge thought leadership programs to ensure that clients are consistently ahead of the curve when it comes to best-in-class market perspectives.
Primary Market Research
With the rapidly changing and increasingly competitive environment – specifically in Pharmaceutical and OTC sectors- companies need sophisticated, holistic insights about the landscape in order to make informed, strategic decisions. IMS Health India’s Primary Market Research offerings answer this need, and help clients drive business growth through industry-leading research, data collection, and competitive intelligence.
